John B MacMillan

Improving natural product research translation: From source to clinical trial.

Daniel Lakens, Dan Xi, Guido F Pauli, 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Using Functional Signature Ontology (FUSION) to Identify Mechanisms of Action for Natural Products

Trey Ideker, Yang Xie, Guanghua Xiao, 2013, Science Signaling.

Development of inhibitors of the PAS-B domain of the HIF-2α transcription factor.

Thomas H Scheuermann, John B MacMillan, Liela Bayeh, 2013, Journal of medicinal chemistry.

Correction: The value of universally available raw NMR data for transparency, reproducibility, and integrity in natural product research.

Jean-Marc Nuzillard, Jean-Hugues Renault, Christoph Steinbeck, 2019, Natural product reports.

A Genome-wide Functional Signature Ontology Map and Applications to Natural Product Mechanism of Action Discovery.

Saurabh Mendiratta, Suzie K. Hight, John B MacMillan, 2019, Cell chemical biology.

Towards patient-based cancer therapeutics

Benito Munoz, Michelle Palmer, Paul A Clemons, 2010, Nature Biotechnology.

Discoipyrroles A-D: isolation, structure determination, and synthesis of potent migration inhibitors from Bacillus hunanensis.

Muhammed Yousufuddin, John B MacMillan, M. White, 2013, Journal of the American Chemical Society.

A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells

John B MacMillan, Robert E. Lewis, M. White, 2018, Scientific Reports.

Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2.

Thomas H Scheuermann, John B MacMillan, Liela Bayeh, 2015, Journal of medicinal chemistry.